These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11117566)

  • 1. Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels.
    Ohmiya M; Hayashi J; Ueno K; Furusyo N; Sawayama Y; Kawakami Y; Kinukawa N; Kashiwagi S
    Dig Dis Sci; 2000 Oct; 45(10):1953-8. PubMed ID: 11117566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.
    Sim H; Yim C; Krajden M; Heathcote J
    Am J Gastroenterol; 1998 Jan; 93(1):39-43. PubMed ID: 9448171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
    Blatt LM; Tong MJ; McHutchison JG; Russell J; Schmid P; Conrad A
    J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.
    Tassopoulos NC; Vafiadis I; Tsantoulas D; Syrokosta J; Hatzis G; Delladetsima JK; Demonakou M; Sypsa V; Hatzakis AE
    J Interferon Cytokine Res; 2002 Mar; 22(3):365-9. PubMed ID: 12034044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
    Basso M; Giannini EG; Torre F; Blanchi S; Savarino V; Picciotto A
    Hepatology; 2009 May; 49(5):1442-8. PubMed ID: 19350657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?
    Bellobuono A; Mondazzi L; Tempini S; Chiodo F; Magliano E; Mondini C; Idéo G
    J Hepatol; 1999 Jan; 30(1):8-13. PubMed ID: 9927145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
    Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
    Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
    Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
    J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early changes in hepatitis C virus (HCV) RNA levels predict response to interferon treatment in noncirrhotic HCV patients.
    Fallows G; Kaita K; Minuk G; Penner F; Smart G; Dawood M; Rosser B
    Can J Gastroenterol; 2000; 14 Suppl B():30B-35B. PubMed ID: 10938502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus.
    Hayashi J; Kawakami Y; Nabeshima A; Kishihara Y; Furusyo N; Sawayama Y; Kinukawa N; Kashiwagi S
    Dig Dis Sci; 1998 Feb; 43(2):384-91. PubMed ID: 9512135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term follow-up of patients with chronic hepatitis C treated with interferon alpha.
    Collier JD; Adams PA; Feinman V; Ghent C; Witt-Sullivan H; Minuk G; Krajden M; Heathcote J
    Can J Gastroenterol; 2000; 14 Suppl B():77B-80B. PubMed ID: 10938510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.
    Tong MJ; Blatt LM; McHutchison JG; Co RL; Conrad A
    Hepatology; 1997 Dec; 26(6):1640-5. PubMed ID: 9398010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with chronic hepatitis C and normal ALT levels.
    Tassopoulos NC
    J Hepatol; 1999; 31 Suppl 1():193-6. PubMed ID: 10622586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.